ArticleJournal of inflammation research2022

B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis.

Anqi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.